Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis
Am J Respir Crit Care Med
.
2024 Aug 15;210(4):521-523.
doi: 10.1164/rccm.202402-0288LE.
Authors
Emily Calamita
1
,
Wing Han Liu
1
,
Patricia P Ogger
1
,
Leia Griffin
1
,
Christina Michalaki
1
,
Faye Murphy
2
,
Julie Worrell
2
,
Cormac McCarthy
2
,
Albert Agro
3
,
Marc Hertz
3
,
Toby M Maher
1
4
,
Clare M Lloyd
1
,
Philip Molyneaux
1
,
Vipin Kumar
5
3
,
Adam J Byrne
1
2
Affiliations
1
National Heart and Lung Institute, Imperial College London, London, United Kingdom.
2
Conway Institute and School of Medicine, University College Dublin, Dublin, Ireland.
3
GRI Bio, La Jolla, California; and.
4
Keck School of Medicine, University of Southern California, Los Angeles, California.
5
Laboratory of Immune Regulation, Department of Medicine, University of California, San Diego, La Jolla, California.
PMID:
38935441
DOI:
10.1164/rccm.202402-0288LE
No abstract available
Publication types
Letter
MeSH terms
Animals
Humans
Mice
Natural Killer T-Cells* / immunology
Pulmonary Fibrosis* / immunology